Mylotarg Европейски съюз - английски - EMA (European Medicines Agency)

mylotarg

pfizer europe ma eeig - gemtuzumab ozogamicin - leukemia, myeloid, acute - antineoplastic agents - mylotarg is indicated for combination therapy with daunorubicin (dnr) and cytarabine (arac) for the treatment of patients age 15 years and above with previously untreated, de novo cd33-positive acute myeloid leukaemia (aml), except acute promyelocytic leukaemia (apl).

MYLOTARG Израел - английски - Ministry of Health

mylotarg

pfizer pharmaceuticals israel ltd - gemtuzumab ozogamicin - powder for concentrate for solution for infusion - gemtuzumab ozogamicin 5 mg/vial - gemtuzumab - mylotarg is indicated for the treatment of newly-diagnosed cd33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older.mylotarg is indicated for the treatment of relapsed or refractory cd33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older…….